Saturday, September 17, 2022

Why Abemaciclib in HR+/HER2- MBC patients?

Dear Dr. Renukaprasad A R,
Do you know that abemaciclib has a potential role in MBC patients with liver metastasis and poor prognosis?

Abemaciclib is found to have significant benefits in treating hormone receptor-positive (HR+) or human epidermal growth receptor-2 negative (HER2-) metastatic breast cancer (MBC) patients, as it can also address factors like liver metastasis and poor prognosis.
Join us for this exclusive webinar on 19th September 2022 at 07:30 PM IST with our renowned experts as they share their perspectives on what influenced them to choose Ramiven� for treating HR+/ HER2- MBC patients and how they tailor the treatment.
Session highlights:
  • Abemaciclib as a first-line therapy - Dr. Anwar Al Nouri
  • Clinical case presentation I - Dr. Anwar Al Nouri
  • Clinical case presentation II - Dr. J. B. Sharma
  • Clinical case presentation III - Dr. Sushant Mittel
  • Clinical case presentation IV - Dr. Samit Purohit
  • Q&A with the experts: Tailoring treatment in HR+/HER2- MBC based on prognostic factors
India's Largest Online Community of Verified Doctors
Pune - 411045, India
info@docplexus.co.in�� |� +91 98500 36954
You are receiving this communication because you are registered member of Docplexus.
Unsubscribe from this mailing list.
*|LIST:DESCRIPTION|* *|LIST:ADDRESS|* *|REWARDS_TEXT|*

PEG-PG-HPG Eye Drops for Squamous Metaplasia Patients

Docplexus - India's Largest Online Community of Verified Doctors
Hi Renukaprasad A R,
Do you know that PEG-PG-HPG eye drops are an effective treatment strategy for squamous metaplasia patients?
Squamous metaplasia occurs when a patient's dry eye disease (DED) worsens. This condition mainly arises from a reduction in tear production and results in the loss of goblet cells in the conjunctival region. Evidence suggests that polyethylene glycol-propylene glycol/hydroxypropyl guar (PEG-PG/HPG) eyedrop helps DED patients by improving DED symptoms and protecting the ocular surface.
Here is an article discussing squamous metaplasia and the efficacy of PEG-PG-HPG artificial tears in treating the condition among DED patients based on evidence from a study.

Highlights:
  • An overview of squamous metaplasia
  • The importance of using PEG-PG-HPG eyedrops to treat the condition
  • Clinical evidence demonstrating the beneficial effects of PEG-PG-HPG eyedrops
Click to Read
Add docplexus to primary
If you don't want to receive these emails in the future, please unsubscribe.
 
Shadow

Cancer-causing Antacid Still Available in India, and More

Hi Renukaprasad A R,
Top Stories of the Day:
Cancer-causing Antacid Still Available in India
US Enters WHO's Polio Outbreak List
Lignocaine Before Surgery in Early Breast Cancer
India: New Insights into Monkeypox Diagnosis
World Patient Safety Day 2022

Healthcare headlines that matter, brought to you every day by Docplexus Health Minute!

Disclaimer: The Health Minute intends to update the medical community about the latest happenings from around the world, including relevant decisions taken by policy-makers. We do not endorse any individual, community, or political party.
India's Largest Online Community Of Verified Doctors
Pune - 411045, India
Unsubscribe from this mailing list.
*|LIST:DESCRIPTION|* *|LIST:ADDRESS|* *|REWARDS_TEXT|*

Friday, September 16, 2022

Expert Opinion: Alcon Dry Eye Digital Knowledge Center

Thursday, September 15, 2022

What Physicians Should Know About AI in Healthcare?

Pregnancy and Diabetes - Join the Session